Patents by Inventor Roger Innes

Roger Innes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11351879
    Abstract: Vehicle depots or yards adapted to charge multiple electric vehicles include multiple charging electrodes to simultaneously direct power to multiple electric vehicles. The charging electrodes may direct power to the electric vehicles from an utility grid or from a secondary power source.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: June 7, 2022
    Assignee: Proterra Operating Company, Inc.
    Inventors: Dustin Grace, Rajiv Singhal, Andre Lalljie, Brian Pevear, Thomas Blazak, Seamus McGrath, John Gerber, Roger Innes
  • Publication number: 20180051297
    Abstract: Compositions, systems and methods are provided for conferring disease resistance to plant pathogens that use proteases to target plant substrate proteins inside plant cells. Briefly, the compositions, systems and methods are based upon plant substrate proteins that are targeted by pathogen-specific proteases and that activate nucleotide binding site-leucine rich repeat (NB-LRR) disease resistance proteins when cleaved by the protease. These substrate proteins are modified such that the endogenous protease recognition sequence is replaced by a protease recognition sequence specific to a different pathogen protease (i.e., a heterologous protease recognition sequence). The modified plant substrate protein therefore can be used in connection with its corresponding NB-LRR protein to activate resistance in response to cleavage by the heterologous pathogen-specific protease. When activated by the plant pathogen-specific protease, the pair initiates host defense responses thereto, including programmed cell death.
    Type: Application
    Filed: October 5, 2017
    Publication date: February 22, 2018
    Inventors: Roger Innes, Sang Hee Kim, Dong Qi
  • Patent number: 9816102
    Abstract: Compositions, systems and methods are provided for conferring disease resistance to plant pathogens that use proteases to target plant substrate proteins inside plant cells. Briefly, the compositions, systems and methods are based upon plant substrate proteins that are targeted by pathogen-specific proteases and that activate nucleotide binding site-leucine rich repeat (NB-LRR) disease resistance proteins when cleaved by the protease. These substrate proteins are modified such that the endogenous protease recognition sequence is replaced by a protease recognition sequence specific to a different pathogen protease (i.e., a heterologous protease recognition sequence). The modified plant substrate protein therefore can be used in connection with its corresponding NB-LRR protein to activate resistance in response to cleavage by the heterologous pathogen-specific protease. When activated by the plant pathogen-specific protease, the pair initiates host defense responses thereto, including programmed cell death.
    Type: Grant
    Filed: September 4, 2013
    Date of Patent: November 14, 2017
    Assignee: Indiana University Research and Technology Corporation
    Inventors: Roger Innes, Sang Hee Kim, Dong Qi
  • Publication number: 20150247163
    Abstract: Compositions, systems and methods are provided for conferring disease resistance to plant pathogens that use proteases to target plant substrate proteins inside plant cells. Briefly, the compositions, systems and methods are based upon plant substrate proteins that are targeted by pathogen-specific proteases and that activate nucleotide binding site-leucine rich repeat (NB-LRR) disease resistance proteins when cleaved by the protease. These substrate proteins are modified such that the endogenous protease recognition sequence is replaced by a protease recognition sequence specific to a different pathogen protease (i.e., a heterologous protease recognition sequence). The modified plant substrate protein therefore can be used in connection with its corresponding NB-LRR protein to activate resistance in response to cleavage by the heterologous pathogen-specific protease. When activated by the plant pathogen-specific protease, the pair initiates host defense responses thereto, including programmed cell death.
    Type: Application
    Filed: September 4, 2013
    Publication date: September 3, 2015
    Inventors: Roger Innes, Sang Hee Kim, Dong Qi